All Tenants
MedicalCredit: S&P: BB+

DaVita Dialysis NNN Properties for Sale in Florida

DaVita Inc. (NYSE: DVA) is the largest dialysis provider in the US with approximately 2,700 centers. DaVita NNN properties trade at wider cap rates due to the company's non-investment-grade credit (BB+), but the specialized build-out and sticky patient relationships make DaVita locations exceptionally difficult to relocate — a key tenant retention factor.

Typical Cap Rate

6.00% - 6.75%

Lease Term

10 - 20 years

Price Range

$2.5M - $5M

Building Size

8,000 - 12,000 SF

Lot Size

0.75 - 1.50 acres

Credit Rating

S&P: BB+

Investment Highlights

Lease Structure

DaVita leases are typically 10-20 year NNN terms with renewal options and 5-10% rent bumps every 5 years. Specialized plumbing, water supply, and electrical requirements make tenant relocations expensive.

DaVita Dialysis Tenant Profile

DaVita operates 2,700+ US dialysis centers and serves ~200,000 patients. Revenue $12B+. Credit: S&P BB+, Moody's Ba2 (non-investment grade but stable). The dialysis market is essentially a duopoly with DaVita and Fresenius.

DaVita Dialysis in Florida

Florida has 200+ DaVita centers. Properties trade at 6-6.75% cap rates depending on lease term and location. Florida's aging population supports long-term dialysis demand.

Why Buy DaVita Dialysis

  • +Sticky tenant with high switching costs
  • +Non-discretionary medical necessity
  • +Wider cap rates than investment-grade NNN
  • +Florida demographic tailwinds
  • +Long-term lease commitments

Considerations

  • Non-investment-grade credit (BB+)
  • Healthcare reimbursement risk (Medicare changes)
  • Specialized build-out creates higher tenant improvements
  • Verify water supply and specialized infrastructure

Related Medical Tenants

Ready to Buy a DaVita Dialysis Property?

We source DaVita DialysisNNN opportunities across Florida. Share your investment criteria and we'll send matching deals within 24 hours.

Get Market Insights Delivered

Weekly Central Florida CRE updates — cap rates, new listings, market trends, and investment opportunities. No spam, unsubscribe anytime.